203.90
3.94%
-8.37
Pre-market:
203.90
Icon Plc stock is traded at $203.90, with a volume of 1.80M.
It is down -3.94% in the last 24 hours and down -31.27% over the past month.
See More
Previous Close:
$212.27
Open:
$212.08
24h Volume:
1.80M
Relative Volume:
1.88
Market Cap:
$17.09B
Revenue:
$8.31B
Net Income/Loss:
$747.89M
P/E Ratio:
32.89
EPS:
6.2
Net Cash Flow:
$1.23B
1W Performance:
-8.91%
1M Performance:
-31.27%
6M Performance:
-34.12%
1Y Performance:
-20.63%
Icon Plc Stock (ICLR) Company Profile
Compare ICLR with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
ICLR | 203.90 | 17.09B | 8.31B | 747.89M | 1.23B | 6.20 |
TMO | 541.90 | 207.84B | 42.37B | 6.14B | 7.78B | 15.26 |
DHR | 241.53 | 173.61B | 23.74B | 3.89B | 4.98B | 7.93 |
A | 134.28 | 38.58B | 6.50B | 1.41B | 1.42B | 3.82 |
IQV | 211.51 | 38.55B | 15.32B | 1.41B | 1.96B | 5.95 |
IDXX | 429.82 | 35.22B | 3.84B | 866.24M | 792.60M | 9.80 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-15-23 | Initiated | Truist | Buy |
Sep-13-23 | Initiated | TD Cowen | Outperform |
Jan-17-23 | Upgrade | Barclays | Equal Weight → Overweight |
Jan-13-23 | Upgrade | Barclays | Equal Weight → Overweight |
Nov-09-22 | Upgrade | BofA Securities | Neutral → Buy |
Sep-07-22 | Initiated | UBS | Buy |
Aug-25-22 | Initiated | Credit Suisse | Neutral |
May-24-22 | Initiated | Guggenheim | Buy |
Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Apr-12-22 | Upgrade | Deutsche Bank | Hold → Buy |
Sep-27-21 | Upgrade | JP Morgan | Neutral → Overweight |
Aug-05-21 | Resumed | Credit Suisse | Outperform |
Jul-23-21 | Upgrade | Citigroup | Neutral → Buy |
Jul-14-21 | Initiated | Citigroup | Neutral |
Apr-13-21 | Resumed | BofA Securities | Neutral |
Apr-01-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Mar-08-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
Mar-03-21 | Initiated | Barclays | Equal Weight |
Mar-01-21 | Upgrade | UBS | Neutral → Buy |
Feb-26-21 | Upgrade | Truist | Hold → Buy |
Jul-24-20 | Downgrade | BofA Securities | Buy → Neutral |
Apr-20-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
Mar-02-20 | Initiated | Deutsche Bank | Hold |
Jan-27-20 | Downgrade | SunTrust | Buy → Hold |
Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
Jan-07-20 | Initiated | Citigroup | Neutral |
Sep-23-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
Jul-26-19 | Upgrade | UBS | Sell → Neutral |
Jan-25-19 | Upgrade | Mizuho | Neutral → Buy |
Oct-26-18 | Upgrade | Evercore ISI | In-line → Outperform |
Oct-09-18 | Initiated | UBS | Sell |
Apr-03-18 | Downgrade | Evercore ISI | Outperform → In-line |
Feb-15-18 | Reiterated | Mizuho | Neutral |
Jan-19-18 | Initiated | Evercore ISI | Outperform |
Oct-27-17 | Reiterated | Barclays | Equal Weight |
Sep-11-17 | Initiated | BofA/Merrill | Buy |
Jul-31-17 | Upgrade | SunTrust | Hold → Buy |
Jul-27-17 | Reiterated | Mizuho | Neutral |
Jun-29-17 | Upgrade | Jefferies | Hold → Buy |
View All
Icon Plc Stock (ICLR) Latest News
ICON Plc stock hits 52-week low at $208.38 amid market shifts - Investing.com
ICON to Present at London Healthcare Conference - TipRanks
ICON plc to Present at the Jefferies London Healthcare Conference - Business Wire
Rose Kidd, ICON – Winner of WMB Businesswoman Award 2024 - Women Mean Business
Icon PLC (ICLR) Shares Up 3.48% on Nov 6 - GuruFocus.com
Life Sciences BPO Market Set to Witness Significant Growth by 2024-2031:Catalent, Inc., Covance, Inc., Fareva, - EIN News
Icon (FRA:IJF) GF Value Rank : 10 (As of Nov. 04, 2024) - GuruFocus.com
ICON Plc stock touches 52-week low at $219.87 amid market shifts - Investing.com Australia
Icon PLC (ICLR) Trading 3.72% Higher on Oct 2 - GuruFocus.com
ICLR Misses on Q3 Earnings, Lowers 2024 Guidance, Stock Falls - Yahoo Finance
ICON's $650 Million Power Play: Can This Bold Move Reverse a 21% Stock Plunge? - Yahoo Finance UK
Baird Downgrades ICON Public Limited (ICLR) - MSN
Icon plc Strengthens Investor Confidence with Secured Notes - TipRanks
Earnings call: ICON PLC faces headwinds, eyes strategic growth By Investing.com - Investing.com Australia
Earnings call: ICON PLC faces headwinds, eyes strategic growth - Investing.com India
Icon Earnings: Shares Tank as Elevated Cancellations Reduce 2024 Guidance - Morningstar
Icon PLC (ICLR) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance
Pharmaceutical Contract Sales Outsourcing (CSO) Market Projected To Witness Substantial Growth, 2024-2031: - EIN News
Icon PLC (ICLR) Q3 2024 Earnings Call Highlights: Navigating Cha - GuruFocus.com
ICON Plc stock touches 52-week low at $227.56 amid market shifts - Investing.com Australia
U.S. Markets Finished Mixed Thursday As Tesla Led, Icon PLC Lagged - Barron's
ICON stock slips after guidance cut (ICLR:NASDAQ) - Seeking Alpha
Icon PLC Down Over 19%, on Pace for Largest Percent Decrease Since March 1999 — Data Talk - Morningstar
ICON Plc stock touches 52-week low at $227.56 amid market shifts By Investing.com - Investing.com South Africa
Baird downgrades ICON plc stock, slashes outlook on lower earnings and revenue guidance - Investing.com
S&P 500 Futures Up in Premarket Trading; Icon PLC, Darling Ingredients Lag - Barron's
ICON revenue slumps 1.2% to USD 2,030M in Q3 2024 - Medical Buyer
Icon PLC: Q3 Earnings Snapshot - Houston Chronicle
Icon PLC (ICLR) Lags Q3 Earnings and Revenue Estimates - Yahoo Finance
ICON Reports Third Quarter 2024 Results - sharewise
ICON Reports Mixed Q3 Results, Secures Key Partnership - TipRanks
Icon PLC: Q3 Earnings Snapshot | National Business News | voiceofalexandria.com - Voice Of Alexandria
ICON plc shares tumble as Q3 results miss estimates, guidance cut - Investing.com Australia
ICON plc shares tumble as Q3 results miss estimates, guidance cut By Investing.com - Investing.com South Africa
Imaging CRO Market Is Booming Worldwide 2025-2030 | WORLDCARE - openPR
Icon PLC (ICLR) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Randomization and Trial Supply Management Market 2024-2031- Calyx, Almac, ICON plc, Trialogics, IBM, Medpace CRO, Endpoi – IndiaPolitics.com - IndiaPolitics.com
Redburn Atlantic Initiates Coverage of ICON Public Limited (ICLR) with Neutral Recommendation - Nasdaq
ICON plc stock faces Neutral rating as analyst flags downside risk to growth projections - Investing.com Australia
Biomarker Research Services Market Synopsis: Trends, Industry Insights, and Growth Forecast 2024-2031 |BioIVT, - EIN News
Onco-hematology Molecular Testing Market Size to Reach USD 1.5 billion by 2031 with a 12.5% CAGR, Boosted by Next-Generation Blood Cancer Diagnostics| Exclusive Report by Transparency Market Research, Inc. - GlobeNewswire Inc.
ICON plc's SWOT analysis: biotech recovery boosts stock amid industry shifts - Investing.com India
ICON plc Schedules Third Quarter 2024 Earnings Conference Call - sharewise
Icon Plc Stock (ICLR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):